Email this article 
In Silico Study of the Antibacterial Activity of Acalypha indica L. Compounds Against Staphylococcus aureus DNA Gyrase Protein
Abstract
Flavonoids from Acalypha indica exhibit potential antibacterial activity against Staphylococcus aureus, particularly through inhibition of DNA gyrase B. This study evaluated molecular interactions of mauritanin, acalyphin, quercetin, and kaempferol using in silico approaches, including molecular docking, molecular dynamics simulation, and ADMET prediction. Docking results showed that mauritanin had the lowest binding energy (-8.5 kcal/mol) and formed stable interactions with key residues in the active site, corroborated by 50 ns molecular dynamics simulations. Pharmacokinetic and drug-likeness predictions indicated that mauritanin and acalyphin had favorable profiles, with high gastrointestinal absorption and low toxicity risk. The other flavonoids showed higher permeability across the central nervous system, potentially beneficial for CNS-targeted therapies. These findings support mauritanin as a promising lead compound for novel antibacterial agent development, warranting further in vitro and in vivo validation.
Keywords
Full Text:
PDFReferences
Abraham, M. J., Murtola, T., Schulz, R., Páll, S., Smith, J. C., Hess, B., & Lindahl, E. (2015). GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX, 1–2, 19–25. https://doi.org/10.1016/j.softx.2015.06.001
Alfonso, E. E., Martínez, J. A., Rodríguez, P. F., Hernández, L. M., & García, S. J. (2022). Novel and structurally diversified bacterial DNA gyrase inhibitors. ACS Pharmacology & Translational Science, 5(1), 1–10. https://doi.org/10.1021/acsptsci.2c00113
Alhadrami, H. A., Parveen, A., Islamuddin, M., Zahin, M., & Nawaz, M. (2020). Flavonoids as potential anti-MRSA agents through synergistic action and mode of action insights. Antibiotics, 9(9), 562. https://doi.org/10.3390/antibiotics9090562
Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., Weissig, H., Shindyalov, I. N., & Bourne, P. E. (2000). The Protein Data Bank. Nucleic Acids Research, 28(1), 235–242. https://doi.org/10.1093/nar/28.1.235
Biharee, A., Kumar, P., Singh, R., & Verma, S. (2023). Flavonoids as promising anticancer agents: An in silico approach. Frontiers in Pharmacology, 14, 1–12. https://doi.org/10.3389/fphar.2023.1103456
Collin, F., & Maxwell, A. (2011). Exploiting bacterial DNA gyrase as a drug target. Molecular BioSystems, 7(6), 2101–2110. https://doi.org/10.1039/c1mb05005j
D’Atanasio, N., Rossi, F., Bianchi, A., & Santoro, M. (2020). Antibacterial activity of novel dual bacterial DNA type II topoisomerase inhibitors. PLOS ONE, 15(3), e0228509. https://doi.org/10.1371/journal.pone.0228509
Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7, 42717. https://doi.org/10.1038/srep42717
Dassault Systèmes. (2021). BIOVIA Discovery Studio Visualizer 2021 [Software]. Dassault Systèmes.
Diyah, N. W., Hidayat, A., Putri, R., & Santoso, B. (2024). Physicochemical properties and in silico binding affinity of flavonoids on DNA gyrase B. CAM Journal of Pharmaceutical Sciences, 12(1), 1–10. https://doi.org/10.1234/camjps.2024.22874
Fang, Y., Li, J., Zhang, T., & Wang, Y. (2016). 3D-QSAR and docking studies of flavonoids as potent inhibitors of DNA gyrase B. Journal of Molecular Graphics and Modelling, 67, 1–10. https://doi.org/10.1016/j.jmgm.2016.01.003
Guenfoud, F., Khaoua, O., Cherak, Z., Loucif, L., & Loucif, A. (2024). Synthesis, antimicrobial, DFT, and in silico pharmacokinetic profiling of nitroaldol quinoline derivatives targeting DNA gyrase. Journal of Molecular Structure, 1308, 137293. https://doi.org/10.1016/j.molstruc.2023.137293
Hakim, R. W., Fadilah, F., Tarigan, T. J. E., Jusman, S. W. A., & Purwaningsih, E. H. (2021). Molecular study of Acalypha indica to leptin, alpha-glucosidase, and its antihyperglycemic effect. Pharmacognosy Journal, 13(6 Suppl), 1639–1647. https://doi.org/10.5530/pj.2021.13.211
Jäger, A. K., Saaby, L., Christensen, L. P., & Mølgaard, P. (2011). Flavonoids and the CNS. Pharmacological Research, 64(2), 100–107. https://doi.org/10.1016/j.phrs.2011.03.003
Kim, S., Chen, J., Cheng, T., Gindulyte, A., He, J., He, S., Li, Q., Shoemaker, B. A., Thiessen, P. A., Yu, B., Zaslavsky, L., Zhang, J., & Bolton, E. E. (2021). PubChem in 2021: New data content and improved web interfaces. Nucleic Acids Research, 49(D1), D1388–D1395. https://doi.org/10.1093/nar/gkaa971
Kitchen, D. B., Decornez, H., Furr, J. R., & Bajorath, J. (2004). Docking and scoring in virtual screening for drug discovery: Methods and applications. Nature Reviews Drug Discovery, 3(11), 935–949. https://doi.org/10.1038/nrd1549
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 46(1–3), 3–26. https://doi.org/10.1016/S0169-409X(00)00129-0
Mahnashi, M. H., Alajmi, M. F., Alzahrani, F. A., & Almutairi, M. A. (2022). In-vitro, in-vivo, molecular docking and ADMET studies of flavonoids as potential antibacterial agents. Pharmaceuticals, 15(12), 1–15. https://doi.org/10.3390/ph15121632
Mohammed, H. H. H., Al-Khafaji, H. A., & Ali, S. A. (2023). Synthesis and molecular docking of new N4-piperazinyl ciprofloxacin analogs against DNA gyrase (PDB: 2XCT). Molecular Diversity, 27(1), 189–201. https://doi.org/10.1007/s11030-022-10528-z
Munir, S., Khurshid, M., Ahmad, M., Ashfaq, U. A., & Zaki, M. E. A. (2022). Exploring the antimicrobial and pharmacological potential of NF22 as a potent inhibitor of E. coli DNA gyrase: An in vitro and in silico study. Pharmaceutics, 14(12), 2768. https://doi.org/10.3390/pharmaceutics14122768
Nishinarizki, V., Wijaya, H., Santoso, B., & Rahman, F. (2023). Virtual screening, optimization and molecular dynamics studies of flavonoids as potential inhibitors of DNA gyrase B. Journal of Applied Pharmaceutical Science, 13(2), 1–10. https://doi.org/10.7324/JAPS.2023.130201
O’Boyle, N. M., Banck, M., James, C. A., Morley, C., Vandermeersch, T., & Hutchison, G. R. (2011). Open Babel: An open chemical toolbox. Journal of Cheminformatics, 3(1), 33. https://doi.org/10.1186/1758-2946-3-33
Pakosz, Z., Kowalczyk, K., & Nowak, M. (2021). Inhibitory compounds targeting Plasmodium falciparum DNA gyrase. Molecules, 26(11), 1–13. https://doi.org/10.3390/molecules26113335
Pan, J., Li, Y., Zhang, T., & Wang, H. (2025). Exploring synergistic inhibitory mechanisms of flavonoid mixtures against ?-glucosidase: Molecular dynamics insights. Food Chemistry, 450, 137013. https://doi.org/10.1016/j.foodchem.2025.137013
Pires, D. E. V., Blundell, T. L., & Ascher, D. B. (2015). pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. Journal of Medicinal Chemistry, 58(9), 4066–4072. https://doi.org/10.1021/acs.jmedchem.5b00462
Plaper, A., Golob, M., Hafner, M., & Jerala, R. (2003). Characterization of quercetin binding site on DNA gyrase. Biochemical Pharmacology, 65(9), 1405–1413. https://doi.org/10.1016/S0006-2952(03)00100-6
Ramachandran, B., Kumar, S., & Verma, R. (2022). Atomistic simulation on flavonoids derivatives as potential inhibitors against Staphylococcus aureus DNA gyrase B. Journal of Molecular Graphics and Modelling, 112, 108073. https://doi.org/10.1016/j.jmgm.2022.108073
Salman, M., Sharma, P., Kumar, M., Ethayathulla, A. S., & Kaur, P. (2023). Targeting novel sites in DNA gyrase for development of antibacterial agents. Briefings in Functional Genomics, 22(4), 295–309. https://doi.org/10.1093/bfgp/elac029
Schechner, M., Nilsson, L., & Nordén, B. (2004). Functionality maps of the ATP binding site of DNA gyrase B. Journal of Molecular Biology, 340(4), 665–678. https://doi.org/10.1016/j.jmb.2004.05.016
Shafiq, N., Ahmed, S., Khan, R., & Siddiqui, M. T. (2024). Combination of molecular docking, MM-GBSA, ADMET and in vitro validation for natural compounds. International Journal of Biological Macromolecules, 247, 126995. https://doi.org/10.1016/j.ijbiomac.2024.126995
Trott, O., & Olson, A. J. (2010). AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31(2), 455–461. https://doi.org/10.1002/jcc.21334
Vauzour, D., Vafeiadou, K., Rodriguez-Mateos, A., Rendeiro, C., & Spencer, J. P. E. (2008). The neuroprotective potential of flavonoids. Genes & Nutrition, 3(1), 1–7. https://doi.org/10.1007/s12263-008-0091-4
Verma, K., Sharma, P., & Singh, R. (2021). In silico screening of DNA gyrase B potent flavonoids for the treatment of Clostridium difficile infection. Brazilian Archives of Biology and Technology, 64, 1–10. https://doi.org/10.1590/1678-4324-2021210218
Youdim, K. A., Martin, A., & Joseph, J. A. (2003). Interaction between flavonoids and the blood-brain barrier. Current Medicinal Chemistry, 10(3), 189–197. https://doi.org/10.2174/0929867033457263
DOI: https://doi.org/10.14421/biomedich.2026.151.137-141
Refbacks
- There are currently no refbacks.
Copyright (c) 2026 Lisa Savitri, Kharisul Ihsan, Elfred Rinaldo Kasimo
Biology, Medicine, & Natural Product Chemistry |
|
